Current Management Guidelines in Thoracic Surgery, An Issue of Thoracic Surgery Clinics - E-Book
This issue highlights management issues surrounding specific subjects within the clinical practice of thoracic surgery. The articles represent areas of thoracic surgery where there may be controversy, lack of consensus, or evolution. Each author summarizes the available literature with the addition of his or her own personal expertise.
What people are saying - Write a review
We haven't found any reviews in the usual places.
General Thoracic Surgery
Physiologic Evaluation of Lung Resection Candidates
Management of Early Stage NonSmall Cell Lung Cancer
Induction Therapy forThymic Malignancies
Management ofBarrett Esophagus with Highgrade Dysplasia
adenocarcinoma amiodarone Ann Thorac Surg antibiotic anticoagulation atrial fibrillation Barrett esophagus beta blockers biopsy bupropion carcinoma cell lung cancer chemoradiation chemoradiotherapy clinical trials clopidogrel compared coronary diagnosis diltiazem disease disease-free survival dose efficacy endoscopic esophageal cancer esophagectomy esophagus etal evaluation evidence February 2012 ISSN follow-up heparin high-grade dysplasia high-risk increased induction therapy infection inthe lobectomy long-term lung cancer lung resection lymph node malignancies mediastinal medications meta-analysis metastases morbidity mortality multimodality NCCN nicotine non-small cell lung non-small-cell lung cancer NSCLC ofthe operative outcome overall survival patients undergoing patientswith perioperative antibiotics placebo pneumonectomy postoperative primary prophylaxis pulmonary function pulmonary metastasectomy pulmonary resection R0 resection radiation therapy radiofrequency ablation radiotherapy randomized trials recommended recurrence reported resection risk factors smoking cessation stage sublobar resection surgeons surgical resection surveillance Thorac Cardiovasc Surg Thorac Oncol thoracic surgery Thoracic Surgery Clinics thoracotomy thromboembolism thymic thymoma tobacco treatment tumors varenicline versus warfarin